Vimal Mehta

Grundare på BIOXCEL THERAPEUTICS, INC.

Förmögenhet: 81 832 $ per 2026-05-31

65 år

37 relationer

Health Technology

Consumer Services

Distribution Services

Profil

Vimal D.
Mehta is the founder of BioXcel Corp., founded in 2005, serving as Chairman & Chief Executive Officer since 2014.
Dr. Mehta is the founder of BioXcel Therapeutics, Inc., founded in 2017, serving as President, Chief Executive Officer & Director since 2021.
Former jobs include Director at Invea Therapeutics, Inc., Manager-Business Development at CuraGen Corp.
from 1996 to 2002, Senior Vice President-Business Development at Alfasigma UK Ltd. from 2002 to 2006, Assistant Professor at The University of Texas Southwestern Medical Center from 1989 to 1996, and Senior Vice President-Business Development at Jubilant Life Sciences (USA), Inc. from 2006 to 2007.
Education includes a doctorate from the University of Delhi.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
BIOXCEL THERAPEUTICS, INC. 0,48 %	2026-06-15	69 942 ( 0,48 % )	81 832 $	2026-05-31

Aktiva positioner av Vimal Mehta

Företag	Position	Start
BIOXCEL THERAPEUTICS, INC.	Grundare	2017-03-29
BioXcel Corp. BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions	Verkställande Direktör	2005-01-01

Alla aktiva positioner av Vimal Mehta

Tidigare kända positioner av Vimal Mehta

Företag	Position	Slut
Invea Therapeutics, Inc. Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs	Direktör/Styrelseledamot	2023-01-01
Jubilant Life Sciences (USA), Inc. Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Wholesales pharmaceuticals	Företagsledare/Principal	2007-01-01
Galapagos Biotech Ltd. Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services	Företagsledare/Principal	2006-01-01
CuraGen Corp. CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products	Företagsledare/Principal	2002-01-01
The University of Texas Southwestern Medical Center The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University	Företagsledare/Principal	1996-01-01

Se detaljerna i Vimal Mehtas erfarenhet

Vimal Mehtas utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Vimal Mehtas erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	8
CuraGen Corp. CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products	Health Technology
Galapagos Biotech Ltd. Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services	Health Technology
University of Delhi University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Texas Southwestern Medical Center The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Jubilant Life Sciences (USA), Inc. Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Wholesales pharmaceuticals	Distribution Services
BioXcel Corp. BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions	Technology Services
BioXcel Therapeutics, Inc. BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology	Health Technology
Invea Therapeutics, Inc. Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs	Health Technology